Cargando…

Proteomic Analysis of Morphologically Changed Tissues after Prolonged Dexamethasone Treatment

Prolonged dexamethasone (Dex) administration leads to serious adverse and decrease brain and heart size, muscular atrophy, hemorrhagic liver, and presence of kidney cysts. Herein, we used an untargeted proteomic approach using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for simultaneou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malkawi, Abeer K., Masood, Afshan, Shinwari, Zakia, Jacob, Minnie, Benabdelkamel, Hicham, Matic, Goran, Almuhanna, Falah, Dasouki, Majed, Alaiya, Ayodele A., Rahman, Anas M. Abdel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650964/ https://www.ncbi.nlm.nih.gov/pubmed/31247941 http://dx.doi.org/10.3390/ijms20133122

Ejemplares similares

Metabolomics Based Profiling of Dexamethasone Side Effects in Rats
por: Malkawi, Abeer K., et al.
Publicado: (2018)

Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis
por: Jacob, Minnie, et al.
Publicado: (2021)

Serum-Based Proteomics Profiling in Adult Patients with Cystic Fibrosis
por: Benabdelkamel, Hicham, et al.
Publicado: (2020)

Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical Isotope Labeling LC-MS Analysis
por: Dahabiyeh, Lina A., et al.
Publicado: (2020)

Proteomic Profiling of the First Human Dental Pulp Mesenchymal Stem/Stromal Cells from Carbonic Anhydrase II Deficiency Osteopetrosis Patients
por: Alkhayal, Zikra, et al.
Publicado: (2020)

Carbonic Anhydrase II Activators in Osteopetrosis Treatment: A Review
por: Alkhayal, Zikra, et al.
Publicado: (2023)

Fluconazole-Induced Protein Changes in Osteogenic and Immune Metabolic Pathways of Dental Pulp Mesenchymal Stem Cells of Osteopetrosis Patients
por: Alkhayal, Zikra, et al.
Publicado: (2023)

Obesity Proteomics: An Update on the Strategies and Tools Employed in the Study of Human Obesity
por: Masood, Afshan, et al.
Publicado: (2018)

LC-MS/MS proteomic analysis revealed novel associations of 37 proteins with T2DM and notable upregulation of immunoglobulins
por: Abdulwahab, Rabab Asghar, et al.
Publicado: (2019)

The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum
por: Alsemari, Abdulaziz, et al.
Publicado: (2014)

Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients
por: Jacob, Minnie, et al.
Publicado: (2023)

Proteomics Investigation of the Impact of the Enterococcus faecalis Secretome on MCF-7 Tumor Cells
por: Alwehaibi, Moudi A., et al.
Publicado: (2023)

Anti-Inflammatory Effect of Specialized Proresolving Lipid Mediators on Mesenchymal Stem Cells: An In Vitro Study
por: AlZahrani, Shahd, et al.
Publicado: (2022)

Sex-Biased Expression of Genes Allocated in the Autosomal Chromosomes: Blood LC-MS/MS Protein Profiling in Healthy Subjects
por: Giha, Hayder A., et al.
Publicado: (2023)

Proteomics Profiling of Osteoporosis and Osteopenia Patients and Associated Network Analysis
por: Al-Ansari, Mysoon M., et al.
Publicado: (2022)

Plasma-Based Proteomics Profiling of Patients with Hyperthyroidism after Antithyroid Treatment
por: Masood, Afshan, et al.
Publicado: (2020)

Proteomics Profiling of the Urine of Patients with Hyperthyroidism after Anti-Thyroid Treatment
por: Benabdelkamel, Hicham, et al.
Publicado: (2021)

Lipidomics Profiling of Patients with Low Bone Mineral Density (LBMD)
por: Aleidi, Shereen M., et al.
Publicado: (2022)

Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin
por: Alshahrani, Awad, et al.
Publicado: (2023)

A Distinctive Human Metabolomics Alteration Associated with Osteopenic and Osteoporotic Patients
por: Aleidi, Shereen M., et al.
Publicado: (2021)

Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy
por: Colak, Dilek, et al.
Publicado: (2016)

Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus
por: Mujammami, Muhammad, et al.
Publicado: (2022)

Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial Cancer
por: Akkour, Khalid, et al.
Publicado: (2022)

Differences in the Plasma Proteome of Patients with Hypothyroidism before and after Thyroid Hormone Replacement: A Proteomic Analysis
por: Alfadda, Assim A., et al.
Publicado: (2018)

Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus
por: Gu, Xinyun, et al.
Publicado: (2020)

Exploring Cardio-Metabolic Effects of Liraglutide in Patients With Type 2 Diabetes Through a Proteomic Approach
por: Ekhzaimy, Aishah Ali, et al.
Publicado: (2021)

Metabolomic profile of patients on levothyroxine treatment for hypothyroidism
por: Benabdelkamel, Hicham, et al.
Publicado: (2023)

Proteomic profiling of thyroid tissue in patients with obesity and benign diffuse goiter
por: Benabdelkamel, Hicham, et al.
Publicado: (2022)

Identification of Protein Changes in the Urine of Hypothyroid Patients Treated with Thyroxine Using Proteomics Approach
por: Masood, Afshan, et al.
Publicado: (2021)

The metabolomics approach revealed a distinctive metabolomics pattern associated with hyperthyroidism treatment
por: Jaber, Malak A., et al.
Publicado: (2022)

A Proteomics-Based Approach Reveals Differential Regulation of Urine Proteins between Metabolically Healthy and Unhealthy Obese Patients
por: Benabdelkamel, Hicham, et al.
Publicado: (2019)

A Proteomics Based Approach Reveals Differential Regulation of Visceral Adipose Tissue Proteins between Metabolically Healthy and Unhealthy Obese Patients
por: Alfadda, Assim A., et al.
Publicado: (2017)

Inhibition of signaling downstream of beta‐2 adrenoceptor by propranolol in prostate cancer cells
por: Alaskar, Aljoharah, et al.
Publicado: (2022)

Proteomic Profiling of Plasma-Derived Biomarkers in Patients with Bladder Cancer: A Step towards Clinical Translation
por: Nedjadi, Taoufik, et al.
Publicado: (2021)

Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment
por: Ekhzaimy, Aishah A, et al.
Publicado: (2022)

Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients
por: Alaiya, Ayodele, et al.
Publicado: (2021)

Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment
por: Rafiullah, Mohamed, et al.
Publicado: (2023)

Metabolomics Distinguishes DOCK8 Deficiency from Atopic Dermatitis: Towards a Biomarker Discovery
por: Jacob, Minnie, et al.
Publicado: (2019)

Metabolomics Profiling of Cystic Renal Disease towards Biomarker Discovery
por: Sriwi, Dalia, et al.
Publicado: (2021)

Comprehensive multi-omics analysis of G6PC3 deficiency-related congenital neutropenia with inflammatory bowel disease
por: Dasouki, Majed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_obopp0lfcu646v3kcmho1thhuv